The nation of Zimbabwe has turned down a significant US health deal valued at $367m (£272m) over five years over the United States' request for sensitive biological samples.
This rejection was revealed after a government memo from December was leaked, revealing that President Emmerson Mnangagwa believed the arrangement was "skewed".
An official representative has since stated that the United States was requesting health data for research and commercial purposes while was unwilling to guarantee the benefits from future vaccines.
"We are forced to start the challenging and unfortunate task of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had furnished over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for continued dialogue to find a agreement suitable to all parties so the nation's vital HIV programme can be sustained.
Broader Implications
This rejection comes after a similar situation in neighbouring Kenya, where a court halted a similar deal with the US after concerns were raised about the security of citizens' medical information.
Since returning to the presidency recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump stated its expenditure was "inefficient" and his administration was seeking direct bilateral agreements to boost transparency and accountability.
As per statements, 16 African countries have to date agreed to these new health pacts, representing more than $18.3bn in new funding.
Details of the Declined Agreement
The money for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership could have provided immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"Our nation was requested to provide its genetic material and health information for a long time, with no equivalent assurance of access to any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"Effectively, our nation would provide the basic resources for medical research with no certainty that the end products would be accessible to our citizens should a new health crisis emerge."
National Interest and International Frameworks
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining structures previously established through the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to manage potential pandemics.
"This mechanism is designed to ensure that when a nation provides its data, the benefits – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to create them."
These objections over the US deal "must not be interpreted as opposition to America," he added.
"We encourage ongoing dialogue with our US partners on how subsequent co-operation might be structured in a way that honours the independence and dignity of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but suggested that negotiations must proceed considering a large portion of the country's HIV programmes relied on foreign aid.
"Where specific concerns exist, such as those relating to data governance or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," it said.
This impasse emphasises the continuing tensions between accepting crucial international aid and safeguarding national sovereignty in an increasingly data-driven world.